ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near - Stocktwits

Source: Stocktwits · 2026-09-27T17:10:48+00:00

ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near Stocktwits

BestAIBroker analysis

Finance-aware sentiment: slightly positive (+0.30 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 24/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: TGT, GS, ARWR.